A study using NF-κ B/p65 nuclear translocation staining as a measure of NF-κB activation found that nuclear immunohistochemical staining was significantly correlated with resistance to neoadjuvant chemotherapy in breast cancer patients [70]. Here, NFKB1 is linked to breast carcinoma.